Joseph C. Papa (born October 1, 1955) is an American businessman and the chairman and chief executive officer (CEO) of Bausch & Lomb, a company formed from the initial public offering (IPO) of the eye health business of Bausch Health Companies Inc.[1] Papa received a bachelor's degree in pharmacy from the University of Connecticut in 1978,[2] and an MBA degree in marketing and finance from Northwestern University's Kellogg Graduate School of Management in 1983.
[5] He was previously chairman and CEO of Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.), having succeeded J. Michael Pearson in those roles in May 2016.
[7] Prior to joining Valeant, Papa was the chairman and CEO of Perrigo, an American manufacturer of private label over-the-counter pharmaceuticals, from 2006 to 2016.
[10] In March 2017, it was reported that Papa received US$62.7 million in total compensation for his first eight months of work in 2016.
[13] In May 2022, Bausch Health reported that Papa’s gross income increased again to $22.9 million, as compared to the $44,617 median compensation of all other Bausch Health employees, reflecting a pay ratio of 513:1.